ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266491 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266491; 2) Community: the network communities that were significantly associated with the response to NSC 266491; 3) Molecule: the relationships between components within communities and NSC 266491; 4) MDR: the compounds that were significantly associated with the NSC 266491.

NSC Compound Enrichment Correlation
NSC 704281 Null 0.0102962192514438 0.53212747
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0102962192514438 0.30139052
NSC 732851 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene 0.0102962192514438 0.46824912
NSC 735318 Null 0.0102962192514438 0.35990144
NSC 740602 Null 0.0102962192514438 0.56980766
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0102962192514438 0.36731369
NSC 88054 Null 0.0102962192514438 0.37005185
NSC 12455 Acid Alizarin Red B 0.0102962192514439 0.35399909
NSC 237020 TA 1067 0.0102962192514439 0.52656849
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0107933723273943 0.55007457
Total:174  Current:51    [First] [Prev] [Next] [Last]